Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effect of Baduanjin Exercise on Pain, Fatigue, and Quality of Recovery After Abdominal Surgery

3. november 2026 oppdatert av: Niran Çoban, University of Yalova

The Effect of Baduanjin Exercise on Pain, Fatigue, and Quality of Recovery in Patients Undergoing Abdominal Surgery: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of Baduanjin exercise on pain, fatigue, fatigue severity, and quality of recovery in patients undergoing abdominal surgery.

A total of 60 participants will be randomly assigned to an intervention group or a control group. Before surgery, participants in the intervention group will receive instruction in Baduanjin exercises and perform the exercises once to learn the technique. After hospital discharge, they will continue the Baduanjin exercise program three days per week for six weeks. Participants in the control group will receive standard hospital care without Baduanjin exercise.

At the end of weeks 3 and 6, pain, fatigue, fatigue severity, and quality of recovery will be assessed using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively. Outcomes will be compared between the intervention and control groups.

Studieoversikt

Status

Har ikke rekruttert ennå

Intervensjon / Behandling

Detaljert beskrivelse

This study aims to evaluate the effects of Baduanjin exercise on pain, fatigue, fatigue severity, and quality of recovery in patients undergoing abdominal surgery. The study is planned as a randomized, controlled, pretest-posttest experimental study involving 60 patients undergoing abdominal surgery at Gümüşhane State Hospital, Türkiye. Participants will be randomly assigned to an intervention group (n=30) or a control group (n=30). Before surgery, participants in the intervention group will be taught how to perform Baduanjin exercises and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Participants in the control group will receive standard hospital care without Baduanjin exercise. At the end of weeks 3 and 6, outcomes will be assessed in both groups using the Visual Analog Scale (VAS) to measure pain intensity, the Fatigue Scale to assess fatigue, the Fatigue Severity Scale to assess fatigue severity, and the Quality of Recovery-40 (QoR-40) questionnaire to evaluate quality of recovery. The results will be compared between the intervention and control groups to determine the effects of the Baduanjin exercise program on pain, fatigue, fatigue severity, and quality of recovery following abdominal surgery.

Studietype

Intervensjonell

Registrering (Antatt)

60

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 70 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Patients aged 18 years and older and younger than 70 years.
  • Patients undergoing abdominal surgery.
  • Patients who voluntarily agree to participate in the study and provide informed consent.
  • Patients with a body mass index (BMI) below 40 kg/m².
  • Patients with a Standardized Mini-Mental State Examination score of 24 or higher.
  • Patients who are able to read and write.

Exclusion Criteria:

  • Patients with communication or comprehension difficulties.
  • Patients who receive sedation.
  • Patients who have difficulty understanding or speaking Turkish.
  • Patients with a psychiatric disorder who are receiving medication.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Ingen inngripen: Standart care

Participants in this group will receive standard hospital care without Baduanjin exercise. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively.

Eksperimentell: Baduanjin Exercise Group

Participants in this group will receive instruction in Baduanjin exercises before surgery and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively.

Participants in the intervention group will be taught Baduanjin exercises before surgery and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
The Effect of Baduanjin on Pain
Tidsramme: At the end of weeks 3 and 6 after hospital discharge.

Visual Analog Scale (VAS): The Visual Analog Scale (VAS) is a commonly used tool for assessing pain. It consists of a 10-cm (100-mm) line ranging from 0 (no pain) to 10 (worst imaginable pain). In this study, the VAS will be used to assess pain in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on pain.

At the end of weeks 3 and 6 after hospital discharge.
The Effect of Baduanjin on Fatigue
Tidsramme: At the end of weeks 3 and 6 after hospital discharge.

Fatigue Scale (FS): The Fatigue Scale was developed by Beurskens et al. in 2000 to assess chronic fatigue. The scale consists of 20 items and evaluates fatigue over the previous two weeks across four dimensions: subjective fatigue perception, concentration, motivation, and physical activity. The Turkish version was validated by Ergin et al. in 2009. The total score ranges from 20 to 140, with higher scores indicating greater chronic fatigue. In this study, the Fatigue Scale will be used to assess fatigue in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on fatigue.

At the end of weeks 3 and 6 after hospital discharge.
The Effect of Baduanjin Exercise on Fatigue Severity
Tidsramme: At the end of weeks 3 and 6 after hospital discharge.

Fatigue Severity Scale (FSS): The Fatigue Severity Scale was developed by Krupp et al. in 1989 to assess fatigue severity, initially in patients with multiple sclerosis and systemic lupus erythematosus. It consists of nine items assessing the subjective severity of fatigue during the previous week. Each item is rated on a seven-point scale, and the total score is calculated as the arithmetic mean of the item scores. Higher scores indicate greater fatigue severity, and a score of approximately 4 or above generally suggests substantial fatigue. The Turkish validity and reliability study was conducted by Gencay Can et al. in 2012. In this study, the Fatigue Severity Scale will be used to assess fatigue severity in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on fatigue severity.

At the end of weeks 3 and 6 after hospital discharge.
The Effect of Baduanjin Exercise on Quality of Recovery
Tidsramme: At the end of weeks 3 and 6 after hospital discharge.

Quality of Recovery-40 (QoR-40): The Quality of Recovery-40 (QoR-40) was developed by Myles et al. in 2000 and its Turkish validity and reliability were evaluated by Karaman et al. in 2014. The questionnaire consists of 40 items across five dimensions: emotional state, physical comfort, patient support, physical independence, and pain. Each item is rated on a five-point Likert scale, and the total score ranges from 40 to 200. Higher scores indicate better postoperative physical and emotional well-being, whereas lower scores indicate poorer quality of recovery. In this study, the QoR-40 will be used to assess quality of recovery in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on postoperative recovery.

At the end of weeks 3 and 6 after hospital discharge.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Samarbeidspartnere

Etterforskere

  • Studieleder: Nurşen Kulakaç, Assoc. Prof., Gümüşhane Universıty

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

30. oktober 2026

Primær fullføring (Antatt)

20. desember 2026

Studiet fullført (Antatt)

20. desember 2026

Datoer for studieregistrering

Først innsendt

24. oktober 2026

Først innsendt som oppfylte QC-kriteriene

24. oktober 2026

Først lagt ut (Faktiske)

30. oktober 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

9. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • NCNK

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere